Combating small molecule aggregation with machine learning
  Biological screens are plagued by false positive hits resulting from
aggregation. Thus, methods to triage small colloidally aggregating molecules
(SCAMs) are in high demand. Herein, we disclose a bespoke machine-learning tool
to confidently and intelligibly flag such entities. Our data demonstrate an
unprecedented utility of machine learning for predicting SCAMs, achieving 80%
of correct predictions in a challenging out-of-sample validation. The tool
outperformed a panel of expert chemists, who correctly predicted 61 +/- 7% of
the same test molecules in a Turing-like test. Further, the computational
routine provided insight into molecular features governing aggregation that had
remained hidden to expert intuition. Leveraging our tool, we quantify that up
to 15-20% of ligands in publicly available chemogenomic databases have the high
potential to aggregate at typical screening concentrations, imposing caution in
systems biology and drug design programs. Our approach provides a means to
augment human intuition, mitigate attrition and a pathway to accelerate future
molecular medicine.
